There is no coincidence that cancer is more frequent as we age. And it is also no coincidence that many anti-aging therapies destined for rejuvenation could allow unleashed growth to take place and cause cancer. Hence my interest in those species which despite an abundant capability to regenerate their damaged tissues, show no increased rate…… Continue reading How to avoid the adverse reactions of senolytics through better design
Tag: aubrey de grey
How to engineer negligible senescence in humans – part VII OncoSENS
What is the number one disease killing our elders besides heart disease? Cancer. A dreadful word that conjures all sorts of evil things, cancer runs rampant as we age. What do all cancers have in common? They start from one (or several) nuclear mutation(s). In the case of lifestyle non-inherited cancers the disease…… Continue reading How to engineer negligible senescence in humans – part VII OncoSENS
How to engineer negligible senescence in humans – part VI RepleniSENS
After a couple of previous articles we reached part VI – the most important of all (in my opinion) because a cell that divides itself in two also dilutes its original damage as well. Having a fresh supply of somatic cells derived from our own DNA would largely correct many of geriatrics diseases. Let’s find…… Continue reading How to engineer negligible senescence in humans – part VI RepleniSENS
How to engineer negligible senescence in humans – part V ApoptoSENS
Where does aging start? There is something inside us that makes us frailer as we count more years – in the beginning we will feel more tired, afterwards we may see our first wrinkles and our graying hair. What’s going on? Where does this time bomb start? Which is the first to age: the body…… Continue reading How to engineer negligible senescence in humans – part V ApoptoSENS